Delivery Order SPE2DR25D3301-SPE2DR26F23LP
Award Date 3/3/26
Potential Completion Date 3/4/26
Potential Value $1.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 2, 2026, for Vivitrol 380 mg vial-diluents with a ceiling value of $6,200.10. The order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to military healthcare programs globally. Place of performance is Conshohocken, PA. The order carries...
- The Defense Logistics Agency issued a $6,655.14 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for VIVITROL 380 mg vial-diluents, with ultimate completion on March 3, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026), which supplies pharmaceutical products and medical supplies to military healthcare programs globally. Place of performance is Conshohocken, PA. Pricing is firm fixed price...
- The Defense Logistics Agency issued a $1,109.19 delivery order to AmerisourceBergen Drug Corp on March 3, 2026, for VIVITROL 380 mg vial-diluents, with a completion date of March 4, 2026. The order was issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), a $999,999,999 IDC through December 2026 that supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA....
- <p>The Defense Logistics Agency issued a $8,873.52 delivery order to AmerisourceBergen Drug Corp on February 9, 2026, for Vivitrol 380 mg vial-diluents, with ultimate completion on February 10, 2026.</p> <p>The order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. Place of performance is Conshohocken, Pennsylvania. The pricing structure is firm fixed price with no set-aside applied.</p>
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Vivitrol 380 mg vial-diluents with a ceiling value of $4,353.89 under firm fixed-price terms. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken, PA....
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 2, 2026, for Vivitrol 380 mg vial-diluents with a ceiling value of $2,804.28. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. Pricing is firm fixed price, with no...
- The Defense Logistics Agency issued a $4,436.76 delivery order to Amerisourcebergen Drug Corp on February 27, 2026, for Vivitrol 380 mg vial-diluents, with an ultimate completion date of March 2, 2026. The order is issued under the parent Indefinite Delivery Contract held by Cencora, Inc. (Amerisourcebergen's parent company) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for $13,052.73 to supply Vivitrol 380 mg vial-diluents under firm fixed-price terms. The order is placed under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999 and running through December 2026. Place of performance is Conshohocken, PA. The ultimate completion date is February 11, 2026. No set-aside was used.
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 20, 2026, for Vivitrol 380 mg vial-diluents with a ceiling value of $3,327.57 and an ultimate completion date of February 23, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is issued under firm fixed-price pricing with no set-aside applied.</p>
- <p>The Defense Logistics Agency issued a $1,109.19 delivery order to AmerisourceBergen Drug Corp on February 18, 2026, for VIVITROL 380 mg vial with diluents.</p> <p>Place of performance is Conshohocken, PA. The order has a ceiling value of $1,109.19 with an ultimate completion date of February 19, 2026. Pricing is firm fixed price. No set-aside was used.</p>
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F23LPDelivery Order
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Vivitrol 380 mg vial-diluents with a ceiling value of $1,109.19. The order is issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, supporting global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, PA. The order carries firm fixed pricing and no set-aside designation. Ultimate completion date is March 4, 2026.
Generated 6/1/26, 10:50 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 3/2/26 |